The Association of Clinical Research Organizations (ACRO) is lead by a distinguished team of business, drug development and technology experts that comprise ACRO’s Board of Directors. Our Board of Directors is dedicated to advocating on behalf of safe, ethical clinical trials that protect patients and ensure high-quality results.
All Regular ACRO members maintain a seat on our Board of Directors. In addition, our Board’s Executive Committee is made up of the current ACRO Chair, Vice-Chair, and the immediate Past-Chair.
ACRO Chair & CEO, ICON
ACRO Vice-Chair and EVP & Head of Product, Medidata Solutions
Previous ACRO Chair & CEO, Syneos Health
President Clinical Operations, IQVIA
Chief Executive Officer, Saama Technologies
Chief Executive Officer, Science37
SVP & GM, Oracle Health Sciences
CEO, Signant Health
CEO, Covance Drug Development
Chief Commercial and Strategy Officer, Parexel
Executive Vice President of Global Clinical Development, PPD
President & CEO, ERT
General Manager, Veeva
Working together with ACRO’s member companies, our staff is committed to leveraging their collective experience in public policy, clinical research, communications and government relations to advance ACRO’s mission on behalf of our industry.
Senior Vice President, Global Regulatory Policy
Vice President, Industry Relations
Director of Government Relations